focus -WSS

focus

author：knowledge 2025-10-02 22:58:41 - browse：5

UnitedHealth Group appears to be offering some providers more substantial loans in the wake of the cyberattack on Change Healthcare, according to three doctors who each saw their advances increase up to seven figures.

The apparent change comes as hospitals, doctors, and lobbying groups have for weeks complained about low offers from the company, in some cases less than 1% of their typical weekly billing. Initially, after a mid-February cyberattack took its system offline, hampering insurers’ ability to receive claims and send payments, UnitedHealth offered loans to bridge the gap while the company worked to fix the outage, but many providers said it didn’t accomplish that.

It’s not clear exactly what prompted the change in these providers’ offers, or how broadly it applies. The new offers came just days after UnitedHealth officials met virtually with Health and Human Services Secretary Xavier Becerra and other White House officials. At that meeting, HHS said it explicitly asked UnitedHealth to send advance payments to providers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： FDA warns J&J's Abiomed: We will regulate your software

focus

WSS

HHS leader on health, climate change and biopharma emissions

Feng Zhang, Grail founder join forces on new gene editing startup

The explosion of genetic testing requires a new approach

Researchers explore possible ties between long Covid, menopause

Why psychiatrists like me stop taking insurance

Why health workers in Gaza are injured or die at high rates

Wikipedia

focus

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

Solve the antibiotic resistance crisis with preventive drugs

Duchenne breakthrough therapy leaves behind pioneering families

The EU Joint Clinical Assessment needs to live up to its promise

Bright Health sells Medicare Advantage business to Molina

GSK Flovent asthma inhalers replaced by authorized generics

After affirmative action ruling, medical educators look to 'holistic review'

AdventHealth escalates lawsuit against insurance vendor Multiplan

How one medical school became remarkably diverse

The biotech scorecard for Q1: 17 stock

hotspot

JPM: CVS says Medicare Advantage patients are impacting profits

Will Ozempic

CEOs share strategies for surviving biotech slump

STAT Summit: How a Chicago ER doctor tackles gun violence

Morgan Health, with ambitious aims, wants you to know it’s still here

Goldman Sachs launches $650M fund for life science investments

knowledge

focus

focus

focus